Table 3

Cox proportional hazard analysis for the relative risk of all-cause and vascular mortality among the access flow groups during the follow-up period

AnalysisAll-cause deathCardiovascular or cerebrovascular death*
HR (95% CI)p ValueHR (95% CI)p Value
 Access flow ≥1000 mL/min1 (reference)1 (reference)
 Access flow <1000 mL/min1.83 (1.35 to 2.49)<0.0011.79 (1.16 to 2.77)0.009
 Access flow ≥1000 mL/min1 (reference)1 (reference)
 Access flow <1000 mL/min1.62 (1.11 to 2.37)0.0131.69 (0.98 to 2.90)0.059
  • *Competing risks with cause-specific hazards.

  • †Adjusted for age; sex; diabetes mellitus; CAD; CHF; CVA; COPD; liver cirrhosis; malignancy; systolic blood pressure; diastolic blood pressure; haemodialysis vintage; vascular access type; ESRD cause; cardiac index; haemoglobin, albumin, cholesterol, ferritin, sodium, potassium, ionised calcium, phosphate and parathyroid hormone levels; Kt/V; and ESA dosage.

  • CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; ESA, erythropoiesis-stimulating agent; ESRD, end-stage renal disease.